Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Monomer sequence in PLGA microparticles: Effects on acidic microclimates and in vivo inflammatory response.

Washington MA, Balmert SC, Fedorchak MV, Little SR, Watkins SC, Meyer TY.

Acta Biomater. 2018 Jan;65:259-271. doi: 10.1016/j.actbio.2017.10.043. Epub 2017 Oct 31.

PMID:
29101019
2.

Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop.

Fedorchak MV, Conner IP, Schuman JS, Cugini A, Little SR.

Sci Rep. 2017 Aug 17;7(1):8639. doi: 10.1038/s41598-017-09379-8.

3.

* Programmed Platelet-Derived Growth Factor-BB and Bone Morphogenetic Protein-2 Delivery from a Hybrid Calcium Phosphate/Alginate Scaffold.

Bayer EA, Jordan J, Roy A, Gottardi R, Fedorchak MV, Kumta PN, Little SR.

Tissue Eng Part A. 2017 Dec;23(23-24):1382-1393. doi: 10.1089/ten.TEA.2017.0027. Epub 2017 Jun 27.

PMID:
28537482
4.

Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease.

Ratay ML, Glowacki AJ, Balmert SC, Acharya AP, Polat J, Andrews LP, Fedorchak MV, Schuman JS, Vignali DAA, Little SR.

J Control Release. 2017 Jul 28;258:208-217. doi: 10.1016/j.jconrel.2017.05.007. Epub 2017 May 10.

PMID:
28501670
5.

The impact of monomer sequence and stereochemistry on the swelling and erosion of biodegradable poly(lactic-co-glycolic acid) matrices.

Washington MA, Swiner DJ, Bell KR, Fedorchak MV, Little SR, Meyer TY.

Biomaterials. 2017 Feb;117:66-76. doi: 10.1016/j.biomaterials.2016.11.037. Epub 2016 Nov 24.

PMID:
27936418
6.

Endophthalmitis Prophylaxis Using a Single Drop of Thermoresponsive Controlled-Release Microspheres Loaded with Moxifloxacin in a Rabbit Model.

Mammen A, Romanowski EG, Fedorchak MV, Dhaliwal DK, Shanks RM, Kowalski RP.

Transl Vis Sci Technol. 2016 Dec 1;5(6):12. eCollection 2016 Dec.

8.

Porous calcium phosphate-poly (lactic-co-glycolic) acid composite bone cement: A viable tunable drug delivery system.

Roy A, Jhunjhunwala S, Bayer E, Fedorchak M, Little SR, Kumta PN.

Mater Sci Eng C Mater Biol Appl. 2016 Feb;59:92-101. doi: 10.1016/j.msec.2015.09.081. Epub 2015 Sep 26.

PMID:
26652353
9.

One-step synthesis of fluorescently labelled, single-walled carbon nanotubes.

Guaragno ML, Gottardi R, Fedorchak MV, Roy A, Kumta PN, Little SR.

Chem Commun (Camb). 2015 Dec 18;51(97):17233-6. doi: 10.1039/c5cc05573c.

PMID:
26458421
10.

Positive Charge of "Sticky" Peptides and Proteins Impedes Release From Negatively Charged PLGA Matrices.

Balmert SC, Zmolek AC, Glowacki AJ, Knab TD, Rothstein SN, Wokpetah JM, Fedorchak MV, Little SR.

J Mater Chem B. 2015 Jun 21;3(23):4723-4734.

11.

Non-Brownian particle-based materials with microscale and nanoscale hierarchy.

Lash MH, Jordan JC, Blevins LC, Fedorchak MV, Little SR, McCarthy JJ.

Angew Chem Int Ed Engl. 2015 May 11;54(20):5854-8. doi: 10.1002/anie.201500273. Epub 2015 Apr 17.

PMID:
25892480
12.

28-day intraocular pressure reduction with a single dose of brimonidine tartrate-loaded microspheres.

Fedorchak MV, Conner IP, Medina CA, Wingard JB, Schuman JS, Little SR.

Exp Eye Res. 2014 Aug;125:210-6. doi: 10.1016/j.exer.2014.06.013. Epub 2014 Jun 28.

PMID:
24983144
13.

Fabrication and characterization of non-Brownian particle-based crystals.

Lash MH, Fedorchak MV, Little SR, McCarthy JJ.

Langmuir. 2015 Jan 27;31(3):898-905. doi: 10.1021/la501511s. Epub 2014 Jul 15.

PMID:
24983125
14.

Gender: resolve bias, don't excuse it.

Fedorchak MV.

Nature. 2014 Jan 30;505(7485):618. doi: 10.1038/505618a. No abstract available.

PMID:
24476877
15.

Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study.

Rimmelé T, Kaynar AM, McLaughlin JN, Bishop JV, Fedorchak MV, Chuasuwan A, Peng Z, Singbartl K, Frederick DR, Zhu L, Carter M, Federspiel WJ, Zeevi A, Kellum JA.

Crit Care. 2013 Mar 26;17(2):R59. doi: 10.1186/cc12587.

16.

Hemoadsorption reprograms inflammation in experimental gram-negative septic peritonitis: insights from in vivo and in silico studies.

Namas RA, Namas R, Lagoa C, Barclay D, Mi Q, Zamora R, Peng Z, Wen X, Fedorchak MV, Valenti IE, Federspiel WJ, Kellum JA, Vodovotz Y.

Mol Med. 2012 Dec 20;18:1366-74. doi: 10.2119/molmed.2012.00106.

17.

Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis.

Peng ZY, Wang HZ, Carter MJ, Dileo MV, Bishop JV, Zhou FH, Wen XY, Rimmelé T, Singbartl K, Federspiel WJ, Clermont G, Kellum JA.

Kidney Int. 2012 Feb;81(4):363-9. doi: 10.1038/ki.2011.320. Epub 2011 Sep 14.

18.

Selective improvement of tumor necrosis factor capture in a cytokine hemoadsorption device using immobilized anti-tumor necrosis factor.

DiLeo MV, Fisher JD, Burton BM, Federspiel WJ.

J Biomed Mater Res B Appl Biomater. 2011 Jan;96(1):127-33. doi: 10.1002/jbm.b.31748.

19.

Scaling issues in the article entitled "cytokines in blood from septic patients interact with surface-immobilized heparin".

Dileo MV, Federspiel WJ.

ASAIO J. 2010 Jul-Aug;56(4):383-4; author reply 384-5. doi: 10.1097/MAT.0b013e3181e4bfc3. No abstract available.

PMID:
20592525
20.

Experimental validation of a theoretical model of cytokine capture using a hemoadsorption device.

DiLeo MV, Fisher JD, Federspiel WJ.

Ann Biomed Eng. 2009 Nov;37(11):2310-6. doi: 10.1007/s10439-009-9780-4. Epub 2009 Aug 14.

Supplemental Content

Loading ...
Support Center